'en:impaired leukocyte chemotaxis'
(id=7032530 ; fe=en:impaired leukocyte chemotaxis ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=4133 creation date=2017-06-25 touchdate=2025-10-03 23:59:00.000) ≈ 115 relations sortantes
- en:impaired leukocyte chemotaxis --
r_associated #0: 42 / 1 ->
en:agglutination
n1=en:impaired leukocyte chemotaxis | n2=en:agglutination | rel=r_associated | relid=0 | w=42
- en:impaired leukocyte chemotaxis --
r_associated #0: 42 / 1 ->
en:antibody variation
n1=en:impaired leukocyte chemotaxis | n2=en:antibody variation | rel=r_associated | relid=0 | w=42
- en:impaired leukocyte chemotaxis --
r_associated #0: 42 / 1 ->
en:hemocyte differentiation
n1=en:impaired leukocyte chemotaxis | n2=en:hemocyte differentiation | rel=r_associated | relid=0 | w=42
- en:impaired leukocyte chemotaxis --
r_associated #0: 40 / 0.952 ->
en:lymphocyte costimulation
n1=en:impaired leukocyte chemotaxis | n2=en:lymphocyte costimulation | rel=r_associated | relid=0 | w=40
- en:impaired leukocyte chemotaxis --
r_associated #0: 40 / 0.952 ->
en:t cell selection
n1=en:impaired leukocyte chemotaxis | n2=en:t cell selection | rel=r_associated | relid=0 | w=40
- en:impaired leukocyte chemotaxis --
r_associated #0: 40 / 0.952 ->
en:tumor escape
n1=en:impaired leukocyte chemotaxis | n2=en:tumor escape | rel=r_associated | relid=0 | w=40
- en:impaired leukocyte chemotaxis --
r_associated #0: 39 / 0.929 ->
en:antigen processing
n1=en:impaired leukocyte chemotaxis | n2=en:antigen processing | rel=r_associated | relid=0 | w=39
- en:impaired leukocyte chemotaxis --
r_associated #0: 38 / 0.905 ->
en:histamine release
n1=en:impaired leukocyte chemotaxis | n2=en:histamine release | rel=r_associated | relid=0 | w=38
- en:impaired leukocyte chemotaxis --
r_associated #0: 37 / 0.881 ->
en:antigen transformation
n1=en:impaired leukocyte chemotaxis | n2=en:antigen transformation | rel=r_associated | relid=0 | w=37
- en:impaired leukocyte chemotaxis --
r_associated #0: 36 / 0.857 ->
en:immunologic specificity
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic specificity | rel=r_associated | relid=0 | w=36
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
déficience leucocytaire du chimiotactisme
n1=en:impaired leukocyte chemotaxis | n2=déficience leucocytaire du chimiotactisme | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:antibody band pattern
n1=en:impaired leukocyte chemotaxis | n2=en:antibody band pattern | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:antigen deletion
n1=en:impaired leukocyte chemotaxis | n2=en:antigen deletion | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:clonal selection, antigen-mediated
n1=en:impaired leukocyte chemotaxis | n2=en:clonal selection, antigen-mediated | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:complement fixation, function
n1=en:impaired leukocyte chemotaxis | n2=en:complement fixation, function | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:immune cell activation process
n1=en:impaired leukocyte chemotaxis | n2=en:immune cell activation process | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:immune clearance
n1=en:impaired leukocyte chemotaxis | n2=en:immune clearance | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:immune system development
n1=en:impaired leukocyte chemotaxis | n2=en:immune system development | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:immunocompetence
n1=en:impaired leukocyte chemotaxis | n2=en:immunocompetence | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:immunologic equivalence
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic equivalence | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:immunoregulation
n1=en:impaired leukocyte chemotaxis | n2=en:immunoregulation | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:passive immunity, function
n1=en:impaired leukocyte chemotaxis | n2=en:passive immunity, function | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 35 / 0.833 ->
en:resistance to infection
n1=en:impaired leukocyte chemotaxis | n2=en:resistance to infection | rel=r_associated | relid=0 | w=35
- en:impaired leukocyte chemotaxis --
r_associated #0: 34 / 0.81 ->
en:antibody formation
n1=en:impaired leukocyte chemotaxis | n2=en:antibody formation | rel=r_associated | relid=0 | w=34
- en:impaired leukocyte chemotaxis --
r_associated #0: 34 / 0.81 ->
en:complement activation
n1=en:impaired leukocyte chemotaxis | n2=en:complement activation | rel=r_associated | relid=0 | w=34
- en:impaired leukocyte chemotaxis --
r_associated #0: 34 / 0.81 ->
en:immune domain
n1=en:impaired leukocyte chemotaxis | n2=en:immune domain | rel=r_associated | relid=0 | w=34
- en:impaired leukocyte chemotaxis --
r_associated #0: 34 / 0.81 ->
en:immunologic attenuation
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic attenuation | rel=r_associated | relid=0 | w=34
- en:impaired leukocyte chemotaxis --
r_associated #0: 34 / 0.81 ->
en:immunologic enhancement
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic enhancement | rel=r_associated | relid=0 | w=34
- en:impaired leukocyte chemotaxis --
r_associated #0: 34 / 0.81 ->
en:immunologic memory
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic memory | rel=r_associated | relid=0 | w=34
- en:impaired leukocyte chemotaxis --
r_associated #0: 34 / 0.81 ->
en:lymphocyte activation process
n1=en:impaired leukocyte chemotaxis | n2=en:lymphocyte activation process | rel=r_associated | relid=0 | w=34
- en:impaired leukocyte chemotaxis --
r_associated #0: 34 / 0.81 ->
en:lympholysis
n1=en:impaired leukocyte chemotaxis | n2=en:lympholysis | rel=r_associated | relid=0 | w=34
- en:impaired leukocyte chemotaxis --
r_associated #0: 32 / 0.762 ->
en:antigenic variation
n1=en:impaired leukocyte chemotaxis | n2=en:antigenic variation | rel=r_associated | relid=0 | w=32
- en:impaired leukocyte chemotaxis --
r_associated #0: 32 / 0.762 ->
en:lymphocyte transformation response
n1=en:impaired leukocyte chemotaxis | n2=en:lymphocyte transformation response | rel=r_associated | relid=0 | w=32
- en:impaired leukocyte chemotaxis --
r_associated #0: 32 / 0.762 ->
en:neutrophil infiltration
n1=en:impaired leukocyte chemotaxis | n2=en:neutrophil infiltration | rel=r_associated | relid=0 | w=32
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:antibody-dependent cellular cytotoxicity
n1=en:impaired leukocyte chemotaxis | n2=en:antibody-dependent cellular cytotoxicity | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:b cell selection
n1=en:impaired leukocyte chemotaxis | n2=en:b cell selection | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:immune absorption
n1=en:impaired leukocyte chemotaxis | n2=en:immune absorption | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:immune response phases
n1=en:impaired leukocyte chemotaxis | n2=en:immune response phases | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:immunologic avidity
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic avidity | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:immunologic capping
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic capping | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:immunologic thermal amplitude
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic thermal amplitude | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:immunomodulation therapy
n1=en:impaired leukocyte chemotaxis | n2=en:immunomodulation therapy | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:seroconversion
n1=en:impaired leukocyte chemotaxis | n2=en:seroconversion | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:susceptibility to infections
n1=en:impaired leukocyte chemotaxis | n2=en:susceptibility to infections | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 31 / 0.738 ->
en:transplantation immunology
n1=en:impaired leukocyte chemotaxis | n2=en:transplantation immunology | rel=r_associated | relid=0 | w=31
- en:impaired leukocyte chemotaxis --
r_associated #0: 30 / 0.714 ->
en:adaptive immunity
n1=en:impaired leukocyte chemotaxis | n2=en:adaptive immunity | rel=r_associated | relid=0 | w=30
- en:impaired leukocyte chemotaxis --
r_associated #0: 30 / 0.714 ->
en:cell-mediated cytotoxicity
n1=en:impaired leukocyte chemotaxis | n2=en:cell-mediated cytotoxicity | rel=r_associated | relid=0 | w=30
- en:impaired leukocyte chemotaxis --
r_associated #0: 30 / 0.714 ->
en:coprecipitation
n1=en:impaired leukocyte chemotaxis | n2=en:coprecipitation | rel=r_associated | relid=0 | w=30
- en:impaired leukocyte chemotaxis --
r_associated #0: 30 / 0.714 ->
en:immune surveillance
n1=en:impaired leukocyte chemotaxis | n2=en:immune surveillance | rel=r_associated | relid=0 | w=30
- en:impaired leukocyte chemotaxis --
r_associated #0: 30 / 0.714 ->
en:immunity
n1=en:impaired leukocyte chemotaxis | n2=en:immunity | rel=r_associated | relid=0 | w=30
- en:impaired leukocyte chemotaxis --
r_associated #0: 30 / 0.714 ->
en:production of molecular mediator of immune response
n1=en:impaired leukocyte chemotaxis | n2=en:production of molecular mediator of immune response | rel=r_associated | relid=0 | w=30
- en:impaired leukocyte chemotaxis --
r_associated #0: 30 / 0.714 ->
en:tolerance induction
n1=en:impaired leukocyte chemotaxis | n2=en:tolerance induction | rel=r_associated | relid=0 | w=30
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:allogeneic inhibition
n1=en:impaired leukocyte chemotaxis | n2=en:allogeneic inhibition | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:anti-complementary activity function
n1=en:impaired leukocyte chemotaxis | n2=en:anti-complementary activity function | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:antigen presentation
n1=en:impaired leukocyte chemotaxis | n2=en:antigen presentation | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:antigen sampling in mucosal-associated lymphoid tissue
n1=en:impaired leukocyte chemotaxis | n2=en:antigen sampling in mucosal-associated lymphoid tissue | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:host defense mechanism
n1=en:impaired leukocyte chemotaxis | n2=en:host defense mechanism | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:immune adherence
n1=en:impaired leukocyte chemotaxis | n2=en:immune adherence | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:immune adsorption
n1=en:impaired leukocyte chemotaxis | n2=en:immune adsorption | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:immune effector process
n1=en:impaired leukocyte chemotaxis | n2=en:immune effector process | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:immune response process
n1=en:impaired leukocyte chemotaxis | n2=en:immune response process | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:immunologic affinity
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic affinity | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 29 / 0.69 ->
en:somatic diversification of immune receptors
n1=en:impaired leukocyte chemotaxis | n2=en:somatic diversification of immune receptors | rel=r_associated | relid=0 | w=29
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:activation of immune response
n1=en:impaired leukocyte chemotaxis | n2=en:activation of immune response | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:aggressor lymphocyte reaction
n1=en:impaired leukocyte chemotaxis | n2=en:aggressor lymphocyte reaction | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:antibody-dependent enhancement
n1=en:impaired leukocyte chemotaxis | n2=en:antibody-dependent enhancement | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:antigen-antibody reactions
n1=en:impaired leukocyte chemotaxis | n2=en:antigen-antibody reactions | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:chemotactic process
n1=en:impaired leukocyte chemotaxis | n2=en:chemotactic process | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:immunogenetic processes
n1=en:impaired leukocyte chemotaxis | n2=en:immunogenetic processes | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:immunologic tolerance
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic tolerance | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:immunopotency
n1=en:impaired leukocyte chemotaxis | n2=en:immunopotency | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:leukocyte trafficking
n1=en:impaired leukocyte chemotaxis | n2=en:leukocyte trafficking | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 28 / 0.667 ->
en:lymphocyte cooperation
n1=en:impaired leukocyte chemotaxis | n2=en:lymphocyte cooperation | rel=r_associated | relid=0 | w=28
- en:impaired leukocyte chemotaxis --
r_associated #0: 27 / 0.643 ->
en:active immunity
n1=en:impaired leukocyte chemotaxis | n2=en:active immunity | rel=r_associated | relid=0 | w=27
- en:impaired leukocyte chemotaxis --
r_associated #0: 27 / 0.643 ->
en:antigen competition
n1=en:impaired leukocyte chemotaxis | n2=en:antigen competition | rel=r_associated | relid=0 | w=27
- en:impaired leukocyte chemotaxis --
r_associated #0: 27 / 0.643 ->
en:complement activation pathway
n1=en:impaired leukocyte chemotaxis | n2=en:complement activation pathway | rel=r_associated | relid=0 | w=27
- en:impaired leukocyte chemotaxis --
r_associated #0: 27 / 0.643 ->
en:immunologic titer
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic titer | rel=r_associated | relid=0 | w=27
- en:impaired leukocyte chemotaxis --
r_associated #0: 27 / 0.643 ->
en:innocent bystander immune reaction
n1=en:impaired leukocyte chemotaxis | n2=en:innocent bystander immune reaction | rel=r_associated | relid=0 | w=27
- en:impaired leukocyte chemotaxis --
r_associated #0: 27 / 0.643 ->
en:mixed lymphocyte culture response
n1=en:impaired leukocyte chemotaxis | n2=en:mixed lymphocyte culture response | rel=r_associated | relid=0 | w=27
- en:impaired leukocyte chemotaxis --
r_associated #0: 27 / 0.643 ->
en:neutrophil activation
n1=en:impaired leukocyte chemotaxis | n2=en:neutrophil activation | rel=r_associated | relid=0 | w=27
- en:impaired leukocyte chemotaxis --
r_associated #0: 26 / 0.619 ->
en:antigen-antibody interaction
n1=en:impaired leukocyte chemotaxis | n2=en:antigen-antibody interaction | rel=r_associated | relid=0 | w=26
- en:impaired leukocyte chemotaxis --
r_associated #0: 26 / 0.619 ->
en:flocculation
n1=en:impaired leukocyte chemotaxis | n2=en:flocculation | rel=r_associated | relid=0 | w=26
- en:impaired leukocyte chemotaxis --
r_associated #0: 26 / 0.619 ->
en:generation of antibody diversity
n1=en:impaired leukocyte chemotaxis | n2=en:generation of antibody diversity | rel=r_associated | relid=0 | w=26
- en:impaired leukocyte chemotaxis --
r_associated #0: 26 / 0.619 ->
en:hemocyte proliferation
n1=en:impaired leukocyte chemotaxis | n2=en:hemocyte proliferation | rel=r_associated | relid=0 | w=26
- en:impaired leukocyte chemotaxis --
r_associated #0: 26 / 0.619 ->
en:immune evasion
n1=en:impaired leukocyte chemotaxis | n2=en:immune evasion | rel=r_associated | relid=0 | w=26
- en:impaired leukocyte chemotaxis --
r_associated #0: 26 / 0.619 ->
en:immunologic precipitation
n1=en:impaired leukocyte chemotaxis | n2=en:immunologic precipitation | rel=r_associated | relid=0 | w=26
- en:impaired leukocyte chemotaxis --
r_associated #0: 26 / 0.619 ->
en:leukocyte homeostasis
n1=en:impaired leukocyte chemotaxis | n2=en:leukocyte homeostasis | rel=r_associated | relid=0 | w=26
- en:impaired leukocyte chemotaxis --
r_associated #0: 26 / 0.619 ->
en:myeloid cell homeostasis
n1=en:impaired leukocyte chemotaxis | n2=en:myeloid cell homeostasis | rel=r_associated | relid=0 | w=26
- en:impaired leukocyte chemotaxis --
r_associated #0: 26 / 0.619 ->
en:phagocytosis
n1=en:impaired leukocyte chemotaxis | n2=en:phagocytosis | rel=r_associated | relid=0 | w=26
- en:impaired leukocyte chemotaxis --
r_associated #0: 25 / 0.595 ->
en:impaired
n1=en:impaired leukocyte chemotaxis | n2=en:impaired | rel=r_associated | relid=0 | w=25
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
adsorption immunitaire
n1=en:impaired leukocyte chemotaxis | n2=adsorption immunitaire | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
clairance immunitaire
n1=en:impaired leukocyte chemotaxis | n2=clairance immunitaire | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
clairance immunologique
n1=en:impaired leukocyte chemotaxis | n2=clairance immunologique | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
coprécipitation
n1=en:impaired leukocyte chemotaxis | n2=coprécipitation | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
cytotoxicité à médiation cellulaire dépendante des ac
n1=en:impaired leukocyte chemotaxis | n2=cytotoxicité à médiation cellulaire dépendante des ac | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
cytotoxicité à médiation cellulaire dépendante des anticorps
n1=en:impaired leukocyte chemotaxis | n2=cytotoxicité à médiation cellulaire dépendante des anticorps | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
cytotoxicité anticorps dépendante
n1=en:impaired leukocyte chemotaxis | n2=cytotoxicité anticorps dépendante | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
cytotoxicité cellulaire anticorps dépendante
n1=en:impaired leukocyte chemotaxis | n2=cytotoxicité cellulaire anticorps dépendante | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
cytotoxicité cellulaire dépendante des anticorps
n1=en:impaired leukocyte chemotaxis | n2=cytotoxicité cellulaire dépendante des anticorps | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
délétion de l'antigène
n1=en:impaired leukocyte chemotaxis | n2=délétion de l'antigène | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
élimination immunitaire
n1=en:impaired leukocyte chemotaxis | n2=élimination immunitaire | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
élimination immunologique
n1=en:impaired leukocyte chemotaxis | n2=élimination immunologique | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
en:complement fixation
n1=en:impaired leukocyte chemotaxis | n2=en:complement fixation | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
en:immunity to infections
n1=en:impaired leukocyte chemotaxis | n2=en:immunity to infections | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
en:immuno-competency
n1=en:impaired leukocyte chemotaxis | n2=en:immuno-competency | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
en:immunoadherence
n1=en:impaired leukocyte chemotaxis | n2=en:immunoadherence | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
facilitation immunologique
n1=en:impaired leukocyte chemotaxis | n2=facilitation immunologique | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
fixation du complément
n1=en:impaired leukocyte chemotaxis | n2=fixation du complément | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
immunoadhérence
n1=en:impaired leukocyte chemotaxis | n2=immunoadhérence | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
immunocompétence
n1=en:impaired leukocyte chemotaxis | n2=immunocompétence | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
inhibition allogénique
n1=en:impaired leukocyte chemotaxis | n2=inhibition allogénique | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
mémoire immunologique
n1=en:impaired leukocyte chemotaxis | n2=mémoire immunologique | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
réaction de déviation du complémen
n1=en:impaired leukocyte chemotaxis | n2=réaction de déviation du complémen | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
résistance aux infections
n1=en:impaired leukocyte chemotaxis | n2=résistance aux infections | rel=r_associated | relid=0 | w=20
- en:impaired leukocyte chemotaxis --
r_associated #0: 20 / 0.476 ->
séroconversion
n1=en:impaired leukocyte chemotaxis | n2=séroconversion | rel=r_associated | relid=0 | w=20
| ≈ 129 relations entrantes
- coprécipitation ---
r_associated #0: 126 -->
en:impaired leukocyte chemotaxis
n1=coprécipitation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=126
- en:coprecipitation ---
r_associated #0: 125 -->
en:impaired leukocyte chemotaxis
n1=en:coprecipitation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=125
- cytotoxicité cellulaire anticorps dépendante ---
r_associated #0: 100 -->
en:impaired leukocyte chemotaxis
n1=cytotoxicité cellulaire anticorps dépendante | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=100
- cytotoxicité à médiation cellulaire dépendante des anticorps ---
r_associated #0: 100 -->
en:impaired leukocyte chemotaxis
n1=cytotoxicité à médiation cellulaire dépendante des anticorps | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=100
- en:antibody-dependent cellular cytotoxicity ---
r_associated #0: 100 -->
en:impaired leukocyte chemotaxis
n1=en:antibody-dependent cellular cytotoxicity | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=100
- cytotoxicité cellulaire dépendante des anticorps ---
r_associated #0: 98 -->
en:impaired leukocyte chemotaxis
n1=cytotoxicité cellulaire dépendante des anticorps | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=98
- cytotoxicité à médiation cellulaire dépendante des ac ---
r_associated #0: 91 -->
en:impaired leukocyte chemotaxis
n1=cytotoxicité à médiation cellulaire dépendante des ac | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=91
- cytotoxicité anticorps dépendante ---
r_associated #0: 86 -->
en:impaired leukocyte chemotaxis
n1=cytotoxicité anticorps dépendante | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=86
- élimination immunologique ---
r_associated #0: 65 -->
en:impaired leukocyte chemotaxis
n1=élimination immunologique | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=65
- en:immune clearance ---
r_associated #0: 62 -->
en:impaired leukocyte chemotaxis
n1=en:immune clearance | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=62
- en:resistance to infection ---
r_associated #0: 61 -->
en:impaired leukocyte chemotaxis
n1=en:resistance to infection | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=61
- facilitation immunologique ---
r_associated #0: 61 -->
en:impaired leukocyte chemotaxis
n1=facilitation immunologique | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=61
- élimination immunitaire ---
r_associated #0: 61 -->
en:impaired leukocyte chemotaxis
n1=élimination immunitaire | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=61
- clairance immunitaire ---
r_associated #0: 60 -->
en:impaired leukocyte chemotaxis
n1=clairance immunitaire | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=60
- en:immunity to infections ---
r_associated #0: 59 -->
en:impaired leukocyte chemotaxis
n1=en:immunity to infections | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=59
- en:complement fixation, function ---
r_associated #0: 58 -->
en:impaired leukocyte chemotaxis
n1=en:complement fixation, function | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=58
- en:immunologic enhancement ---
r_associated #0: 57 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic enhancement | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=57
- résistance aux infections ---
r_associated #0: 57 -->
en:impaired leukocyte chemotaxis
n1=résistance aux infections | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=57
- clairance immunologique ---
r_associated #0: 56 -->
en:impaired leukocyte chemotaxis
n1=clairance immunologique | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=56
- fixation du complément ---
r_associated #0: 55 -->
en:impaired leukocyte chemotaxis
n1=fixation du complément | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=55
- en:immune adherence ---
r_associated #0: 54 -->
en:impaired leukocyte chemotaxis
n1=en:immune adherence | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=54
- immunoadhérence ---
r_associated #0: 51 -->
en:impaired leukocyte chemotaxis
n1=immunoadhérence | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=51
- en:complement fixation ---
r_associated #0: 50 -->
en:impaired leukocyte chemotaxis
n1=en:complement fixation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=50
- en:antigen deletion ---
r_associated #0: 46 -->
en:impaired leukocyte chemotaxis
n1=en:antigen deletion | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=46
- délétion de l'antigène ---
r_associated #0: 45 -->
en:impaired leukocyte chemotaxis
n1=délétion de l'antigène | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=45
- séroconversion ---
r_associated #0: 44 -->
en:impaired leukocyte chemotaxis
n1=séroconversion | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=44
- en:immune adsorption ---
r_associated #0: 41 -->
en:impaired leukocyte chemotaxis
n1=en:immune adsorption | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=41
- en:seroconversion ---
r_associated #0: 40 -->
en:impaired leukocyte chemotaxis
n1=en:seroconversion | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=40
- adsorption immunitaire ---
r_associated #0: 37 -->
en:impaired leukocyte chemotaxis
n1=adsorption immunitaire | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=37
- en:active immunity ---
r_associated #0: 35 -->
en:impaired leukocyte chemotaxis
n1=en:active immunity | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=35
- en:adaptive immunity ---
r_associated #0: 35 -->
en:impaired leukocyte chemotaxis
n1=en:adaptive immunity | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=35
- en:antibody formation ---
r_associated #0: 35 -->
en:impaired leukocyte chemotaxis
n1=en:antibody formation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=35
- en:immunocompetence ---
r_associated #0: 35 -->
en:impaired leukocyte chemotaxis
n1=en:immunocompetence | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=35
- immunocompétence ---
r_associated #0: 35 -->
en:impaired leukocyte chemotaxis
n1=immunocompétence | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=35
- en:immunoadherence ---
r_associated #0: 34 -->
en:impaired leukocyte chemotaxis
n1=en:immunoadherence | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=34
- déficience leucocytaire du chimiotactisme ---
r_associated #0: 32 -->
en:impaired leukocyte chemotaxis
n1=déficience leucocytaire du chimiotactisme | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=32
- en:immuno-competency ---
r_associated #0: 32 -->
en:impaired leukocyte chemotaxis
n1=en:immuno-competency | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=32
- en:innocent bystander immune reaction ---
r_associated #0: 32 -->
en:impaired leukocyte chemotaxis
n1=en:innocent bystander immune reaction | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=32
- en:neutrophil infiltration ---
r_associated #0: 32 -->
en:impaired leukocyte chemotaxis
n1=en:neutrophil infiltration | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=32
- en:allogeneic inhibition ---
r_associated #0: 31 -->
en:impaired leukocyte chemotaxis
n1=en:allogeneic inhibition | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=31
- en:cell-mediated cytotoxicity ---
r_associated #0: 31 -->
en:impaired leukocyte chemotaxis
n1=en:cell-mediated cytotoxicity | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=31
- en:immunologic avidity ---
r_associated #0: 31 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic avidity | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=31
- en:immunologic tolerance ---
r_associated #0: 31 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic tolerance | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=31
- inhibition allogénique ---
r_associated #0: 31 -->
en:impaired leukocyte chemotaxis
n1=inhibition allogénique | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=31
- mémoire immunologique ---
r_associated #0: 31 -->
en:impaired leukocyte chemotaxis
n1=mémoire immunologique | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=31
- en:immunologic capping ---
r_associated #0: 30 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic capping | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=30
- en:tumor escape ---
r_associated #0: 30 -->
en:impaired leukocyte chemotaxis
n1=en:tumor escape | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=30
- en:immunologic memory ---
r_associated #0: 29 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic memory | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=29
- en:immune absorption ---
r_associated #0: 28 -->
en:impaired leukocyte chemotaxis
n1=en:immune absorption | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=28
- en:immune evasion ---
r_associated #0: 28 -->
en:impaired leukocyte chemotaxis
n1=en:immune evasion | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=28
- en:immunologic affinity ---
r_associated #0: 27 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic affinity | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=27
- en:mixed lymphocyte culture response ---
r_associated #0: 27 -->
en:impaired leukocyte chemotaxis
n1=en:mixed lymphocyte culture response | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=27
- réaction de déviation du complémen ---
r_associated #0: 27 -->
en:impaired leukocyte chemotaxis
n1=réaction de déviation du complémen | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=27
- affinité immunitaire ---
r_associated #0: 25 -->
en:impaired leukocyte chemotaxis
n1=affinité immunitaire | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=25
- affinité immunologique ---
r_associated #0: 25 -->
en:impaired leukocyte chemotaxis
n1=affinité immunologique | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=25
- adhérence immune ---
r_associated #0: 22 -->
en:impaired leukocyte chemotaxis
n1=adhérence immune | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=22
- cytotoxicité à médiation cellulaire ---
r_associated #0: 21 -->
en:impaired leukocyte chemotaxis
n1=cytotoxicité à médiation cellulaire | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=21
- en:activation of immune response ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:activation of immune response | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:agglutination ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:agglutination | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:aggressor lymphocyte reaction ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:aggressor lymphocyte reaction | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:anti-complementary activity function ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:anti-complementary activity function | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antibody band pattern ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antibody band pattern | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antibody variation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antibody variation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antibody-dependent enhancement ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antibody-dependent enhancement | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antigen competition ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antigen competition | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antigen presentation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antigen presentation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antigen processing ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antigen processing | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antigen sampling in mucosal-associated lymphoid tissue ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antigen sampling in mucosal-associated lymphoid tissue | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antigen transformation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antigen transformation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antigen-antibody interaction ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antigen-antibody interaction | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antigen-antibody reactions ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antigen-antibody reactions | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:antigenic variation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:antigenic variation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:b cell selection ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:b cell selection | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:chemotactic process ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:chemotactic process | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:clonal selection, antigen-mediated ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:clonal selection, antigen-mediated | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:complement activation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:complement activation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:complement activation pathway ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:complement activation pathway | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:flocculation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:flocculation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:generation of antibody diversity ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:generation of antibody diversity | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:hemocyte differentiation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:hemocyte differentiation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:hemocyte proliferation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:hemocyte proliferation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:histamine release ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:histamine release | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:host defense mechanism ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:host defense mechanism | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immune cell activation process ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immune cell activation process | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immune domain ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immune domain | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immune effector process ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immune effector process | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immune response phases ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immune response phases | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immune response process ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immune response process | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immune surveillance ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immune surveillance | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immune system development ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immune system development | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunity ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunity | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunogenetic processes ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunogenetic processes | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunologic attenuation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic attenuation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunologic equivalence ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic equivalence | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunologic precipitation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic precipitation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunologic specificity ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic specificity | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunologic thermal amplitude ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic thermal amplitude | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunologic titer ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunologic titer | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunomodulation therapy ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunomodulation therapy | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunopotency ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunopotency | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:immunoregulation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:immunoregulation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:leukocyte homeostasis ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:leukocyte homeostasis | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:leukocyte trafficking ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:leukocyte trafficking | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:lymphocyte activation process ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:lymphocyte activation process | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:lymphocyte cooperation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:lymphocyte cooperation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:lymphocyte costimulation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:lymphocyte costimulation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:lymphocyte transformation response ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:lymphocyte transformation response | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:lympholysis ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:lympholysis | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:myeloid cell homeostasis ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:myeloid cell homeostasis | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:neutrophil activation ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:neutrophil activation | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:passive immunity, function ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:passive immunity, function | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:phagocytosis ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:phagocytosis | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:production of molecular mediator of immune response ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:production of molecular mediator of immune response | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:somatic diversification of immune receptors ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:somatic diversification of immune receptors | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:susceptibility to infections ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:susceptibility to infections | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:t cell selection ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:t cell selection | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:tolerance induction ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:tolerance induction | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- en:transplantation immunology ---
r_associated #0: 20 -->
en:impaired leukocyte chemotaxis
n1=en:transplantation immunology | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=20
- immuno-adhérence ---
r_associated #0: 15 -->
en:impaired leukocyte chemotaxis
n1=immuno-adhérence | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=15
- Immunocompétence ---
r_associated #0: 10 -->
en:impaired leukocyte chemotaxis
n1=Immunocompétence | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=10
- Mémoire immunologique ---
r_associated #0: 10 -->
en:impaired leukocyte chemotaxis
n1=Mémoire immunologique | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=10
- mémoire (étapes et formes) ---
r_associated #0: 10 -->
en:impaired leukocyte chemotaxis
n1=mémoire (étapes et formes) | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=10
- tolérance immunitaire ---
r_associated #0: 10 -->
en:impaired leukocyte chemotaxis
n1=tolérance immunitaire | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=10
- échappement tumoral ---
r_associated #0: 10 -->
en:impaired leukocyte chemotaxis
n1=échappement tumoral | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=10
- Séroconversion ---
r_associated #0: 5 -->
en:impaired leukocyte chemotaxis
n1=Séroconversion | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=5
- costimulation lymphocytaire ---
r_associated #0: 5 -->
en:impaired leukocyte chemotaxis
n1=costimulation lymphocytaire | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=5
- processus d'activation lymphocytaire ---
r_associated #0: 5 -->
en:impaired leukocyte chemotaxis
n1=processus d'activation lymphocytaire | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=5
- réponse de culture lymphocytaire mixte ---
r_associated #0: 5 -->
en:impaired leukocyte chemotaxis
n1=réponse de culture lymphocytaire mixte | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=5
- transformation de l'antigène ---
r_associated #0: 5 -->
en:impaired leukocyte chemotaxis
n1=transformation de l'antigène | n2=en:impaired leukocyte chemotaxis | rel=r_associated | relid=0 | w=5
|